2705, boulevard Laurier
R0-709
Québec, Québec
Canada G1V 4G2
Dernières nouvelles
- Font Lavagna, Juan PabloEmployéCHUL+1 418-525-4444, poste 48110juan-pablo.font-lavagna@crchudequebec.ulaval.ca
2705, boulevard Laurier
R-0709
Québec, QC
Canada G1V 4G2 - Gilbert, MéganEmployémegan.gilbert@crchudequebec.ulaval.ca
- Ovyn, ManonStagiaireCHUL+1 418-525-4444manon.ovyn@crchudequebec.ulaval.ca
2705, boulevard Laurier
Québec, QC
Canada G1V 4G2 - Pageau, KimEmployékim.pageau@crchudequebec.ulaval.ca
- Rabezanahary, HenintsoaEmployéCHUL+1 418-525-4444, poste 48110+1 418-654-2715Henintsoa.Rabezanaha@crchudequebec.ulaval.ca
2705, boulevard Laurier
R-0709
Québec, Québec
Canada G1V 4G2 - Sahli, AhmedÉtudiant 3e cycleCHUL+1 418-525-4444, poste 48110ahmed.sahli@crchudequebec.ulaval.ca
2705, boulevard Laurier
R-0709
Québec, QC
Canada G1V 4G2 - Scarrone, MartinaEmployéCHULmartina.scarrone@crchudequebec.ulaval.ca
2705, boulevard Laurier
Québec, QC
Canada G1V 4G2 - Wantchecon, Croix AudeÉtudiant 2e cycleCHUL+1 418-525-4444, poste 48110aude.wantchecon-croix@crchudequebec.ulaval.ca
2705, boulevard Laurier
R-0709
Québec, QC
Canada G1V 4G2
Quillaja brasiliensis nanoparticle adjuvant formulation improves the efficacy of an inactivated trivalent influenza vaccine in mice
Article de revueFront Immunol, 14 , 2023.
Detection and genome characterisation of SARS-CoV-2 P.6 lineage in dogs and cats living with Uruguayan COVID-19 patients
Article de revueMem Inst Oswaldo Cruz, 117 , 2023.
Symptomatology during previous SARS-CoV-2 infection and serostatus before vaccination influence the immunogenicity of BNT162b2 COVID-19 mRNA vaccine
Article de revueFront Immunol, 13 , 2022.
Epigallocatechin Gallate and Isoquercetin Synergize With Remdesivir to Reduce SARS-CoV-2 Replication In Vitro
Article de revueFront Virol, 2 , 2022.
SARS-CoV-2 Omicron BA.1 Challenge after Ancestral or Delta Infection in Mice
Article de revueEmerg Infect Dis, 28 (11), 2022.
Report on influenza viruses received and tested by the Melbourne WHO Collaborating Centre for Reference and Research on Influenza during 2020-2021
Article de revueCommun Dis Intell (2018), 46 , 2022.
Cross-reactive immunity against SARS-CoV-2 N protein in Central and West Africa precedes the COVID-19 pandemic
Article de revueSci Rep, 12 (1), 2022.
A nanoparticle-based COVID-19 vaccine candidate elicits broad neutralizing antibodies and protects against SARS-CoV-2 infection
Article de revueNanomedicine, 44 , 2022.
World Society for Virology first international conference: Tackling global virus epidemics
Article de revueVirology, 566 , 2022.
Characterization of influenza B viruses with reduced susceptibility to influenza neuraminidase inhibitors
Article de revueAntiviral Res, 200 , 2022.
Projets actifs
- Aerosol Infection Research: Better mOdels to Reduce iNdoor Exposure (AIRBORNE), du 2022-06-01 au 2025-05-30
- Canada Research Chair in Pre-pandemic and Pandemic viruses and therapeutic strategies, du 2023-05-01 au 2028-04-29
- Chaire de recherche Sentinelle Nord sur les virus pandémique et thérapies antivirales, du 2022-04-01 au 2025-03-31
- Développement de tests sérologiques pour les virus respiratoires et les virus de la variole du singe., du 2023-04-01 au 2026-03-31
- Immunité cellulaire et séroprévalence des anticorps contre SARS-COV-2: Caractérisation de trois populations de travailleurs de l'alimentation, du 2020-11-01 au 2023-09-30
- Innovative therapeutic approaches for the 2019-novel coronavirus, du 2021-03-01 au 2024-03-31
- Optimization of a live microneutralization assay to evaluate antibody levels against mpox in vaccinated or infected individuals in Quebec, du 2023-04-24 au 2024-04-23
- Plateforme de laboratoire de niveau de confinement 3 pour la recherche sur les virus émergents, du 2023-01-31 au 2025-03-31
- Preclinical proof of concept studies of a new generation of TLR7/8 agonist used in prevention against respiratory viruses and in immunotherapy against lung cancer, du 2023-03-01 au 2024-02-29
Projets terminés récemment
- Effects of high polyphenol doses on the replication of COVID-19 in vitro, du 2020-06-01 au 2021-11-30
- Fonds de démarrage, Mariana Baz. La grippe à l'interface entre l'homme et l'animal: émergence et contrôle, du 2020-04-13 au 2023-04-12
- Prevention of the immunopathology induced by SARS-CoV-2, du 2021-06-01 au 2022-05-31
- Understanding the pathogenesis of COVID-19, du 2020-03-01 au 2023-02-28